Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors

NCT02688101 is registered in ClinicalTrials.gov with Collaborative Medicinal Development Pty Limited as lead sponsor.

NCT NCT02688101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02688101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors
Lead sponsor
Collaborative Medicinal Development Pty Limited
Phase
Phase 1
Overall status
Completed
Start date
April 11, 2016
Completion date
October 26, 2017
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms